501 related articles for article (PubMed ID: 14576974)
21. Temporal changes of urinary oxidative metabolites of di(2-ethylhexyl)phthalate after the 2011 phthalate incident in Taiwanese children: findings of a six month follow-up.
Wu CF; Chen BH; Shiea J; Chen EK; Liu CK; Chao MC; Ho CK; Wu JR; Wu MT
Environ Sci Technol; 2013 Dec; 47(23):13754-62. PubMed ID: 24191740
[TBL] [Abstract][Full Text] [Related]
22. Exposure to Mixed Phthalates in Czech Preschool and School Children.
Puklová V; Janoš T; Sochorová L; Vavrouš A; Vrbík K; Fialová A; Hanzlíková L; Černá M
Arch Environ Contam Toxicol; 2019 Nov; 77(4):471-479. PubMed ID: 31214748
[TBL] [Abstract][Full Text] [Related]
23. Assessment of di (2-ethylhexyl) phthalate exposure by urinary metabolites as a function of sampling time.
Park MS; Yang YJ; Hong YP; Kim SY; Lee YP
J Prev Med Public Health; 2010 Jul; 43(4):301-8. PubMed ID: 20689356
[TBL] [Abstract][Full Text] [Related]
24. Disposition of orally administered di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate in the rat.
Teirlynck OA; Belpaire F
Arch Toxicol; 1985 Sep; 57(4):226-30. PubMed ID: 4091646
[TBL] [Abstract][Full Text] [Related]
25. The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism.
Lhuguenot JC; Mitchell AM; Milner G; Lock EA; Elcombe CR
Toxicol Appl Pharmacol; 1985 Aug; 80(1):11-22. PubMed ID: 4024100
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of orally administered di(2-ethylhexyl) phthalate and its metabolite, mono(2-ethylhexyl) phthalate, in male pigs.
Ljungvall K; Tienpont B; David F; Magnusson U; Törneke K
Arch Toxicol; 2004 Jul; 78(7):384-9. PubMed ID: 15022035
[TBL] [Abstract][Full Text] [Related]
27. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population.
Koch HM; Drexler H; Angerer J
Int J Hyg Environ Health; 2003 Mar; 206(2):77-83. PubMed ID: 12708228
[TBL] [Abstract][Full Text] [Related]
28. Case study: Possible differences in phthalates exposure among the Czech, Hungarian, and Slovak populations identified based on the DEMOCOPHES pilot study results.
Černá M; Malý M; Rudnai P; Középesy S; Náray M; Halzlová K; Jajcaj M; Grafnetterová A; Krsková A; Antošová D; Forysová K; Den Hond E; Schoeters G; Joas R; Casteleyn L; Joas A; Biot P; Aerts D; Angerer J; Bloemen L; Castaño A; Esteban M; Koch HM; Kolossa-Gehring M; Gutleb AC; Pavloušková J; Vrbík K
Environ Res; 2015 Aug; 141():118-24. PubMed ID: 25532669
[TBL] [Abstract][Full Text] [Related]
29. Occurrence and daily variation of phthalate metabolites in the urine of an adult population.
Fromme H; Bolte G; Koch HM; Angerer J; Boehmer S; Drexler H; Mayer R; Liebl B
Int J Hyg Environ Health; 2007 Jan; 210(1):21-33. PubMed ID: 17182278
[TBL] [Abstract][Full Text] [Related]
30. Austrian reference values for phthalate metabolite exposure in children/adolescents and adults.
Hartmann C; Uhl M; Weiss S; Scharf S; König J
Int J Hyg Environ Health; 2018 Jul; 221(6):985-989. PubMed ID: 29908910
[TBL] [Abstract][Full Text] [Related]
31. [Material monograph on di(2-ethylhexyl)phthalat (DEHP)--reference values for 5oxo-MEHP und 5OH-MEHP in urine].
Stellungnahme der Kommission Human-Biomonitoring des Umweltbundesamtes
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Jun; 48(6):706-22. PubMed ID: 15983852
[No Abstract] [Full Text] [Related]
32. Metabolite profiling and identification in human urine after single oral administration of DEHP.
Kurata Y; Shimamura N; Katoh M
J Toxicol Sci; 2012; 37(2):401-14. PubMed ID: 22467031
[TBL] [Abstract][Full Text] [Related]
33. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
Barr DB; Silva MJ; Kato K; Reidy JA; Malek NA; Hurtz D; Sadowski M; Needham LL; Calafat AM
Environ Health Perspect; 2003 Jul; 111(9):1148-51. PubMed ID: 12842765
[TBL] [Abstract][Full Text] [Related]
34. Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets.
Kessler W; Numtip W; Grote K; Csanády GA; Chahoud I; Filser JG
Toxicol Appl Pharmacol; 2004 Mar; 195(2):142-53. PubMed ID: 14998681
[TBL] [Abstract][Full Text] [Related]
35. Phthalate exposure in pregnant women and their children in central Taiwan.
Lin S; Ku HY; Su PH; Chen JW; Huang PC; Angerer J; Wang SL
Chemosphere; 2011 Feb; 82(7):947-55. PubMed ID: 21075419
[TBL] [Abstract][Full Text] [Related]
36. Dispositions of di- and mono-(2-ethylhexyl) phthalate in newborn infants subjected to exchange transfusions.
Sjöberg P; Bondesson U; Sedin G; Gustafsson J
Eur J Clin Invest; 1985 Dec; 15(6):430-6. PubMed ID: 3938415
[TBL] [Abstract][Full Text] [Related]
37. Metabolism and urinary excretion kinetics of di(2-ethylhexyl) terephthalate (DEHTP) in three male volunteers after oral dosage.
Lessmann F; Schütze A; Weiss T; Langsch A; Otter R; Brüning T; Koch HM
Arch Toxicol; 2016 Jul; 90(7):1659-67. PubMed ID: 27116293
[TBL] [Abstract][Full Text] [Related]
38. Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling.
Adachi K; Suemizu H; Murayama N; Shimizu M; Yamazaki H
Environ Toxicol Pharmacol; 2015 May; 39(3):1067-73. PubMed ID: 25867688
[TBL] [Abstract][Full Text] [Related]
39. Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment.
Silva MJ; Reidy JA; Preau JL; Samandar E; Needham LL; Calafat AM
Biomarkers; 2006; 11(1):1-13. PubMed ID: 16484133
[TBL] [Abstract][Full Text] [Related]
40. Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP.
Koch HM; Angerer J
Int J Hyg Environ Health; 2007 Jan; 210(1):9-19. PubMed ID: 17182279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
